Health and Human Services News and Research RSS Feed - Health and Human Services News and Research

Care4Moms study to identify, address health care needs of mothers with medically fragile infants

Care4Moms study to identify, address health care needs of mothers with medically fragile infants

An interdisciplinary team of researchers at the University of North Carolina at Chapel Hill School of Medicine has received nearly $900,000 in federal funding to identify and address the needs of mothers with medically fragile infants, a vastly understudied group. [More]
Study reveals unexpected process for acquiring chemoresistance in breast cancers

Study reveals unexpected process for acquiring chemoresistance in breast cancers

A laboratory study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes. [More]
Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Scientists discover vaccine-induced antibodies that can counteract varied strains of influenza virus

Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans. [More]
Researchers identify specific pathways involved in development of mucormycosis

Researchers identify specific pathways involved in development of mucormycosis

Research published today in the journal, Nature Communications, provides new insights into the evolution of Mucorales fungi, which cause a fatal infection in ever-increasing segments of patient population, and several molecular pathways that might be exploited as potential therapeutic or diagnostic targets. [More]
Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

Texas Biomed scientists receive $23 million NIH grant to develop AIDS vaccine

To support a coordinated, innovative approach to the development of an AIDS vaccine, Texas Biomedical Research Institute scientists, together with a multi-institutional coalition of experts from the United States and Europe, have received a grant for $23 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. [More]
Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Combining ART with immune-enhancing treatment may destabilize HIV reservoirs

Although antiretroviral therapy (ART) can reduce the amount of HIV in the blood to an undetectable level in most chronically infected people, it cannot eliminate reservoirs of HIV that persist in latently infected immune cells. [More]
Experts call to make parenting a national priority

Experts call to make parenting a national priority

Ask any mom or dad and they will tell you: parenting is hard work. For those parents and caregivers who struggle with the nature or the demands of child rearing, sometimes help is hard to find. [More]
UTHealth researchers receive grant to help mobile clinics optimize health care services

UTHealth researchers receive grant to help mobile clinics optimize health care services

The National Science Foundation has awarded $250,000 to researchers at The University of Texas Health Science Center at Houston for a project that will help mobile health clinics in Houston optimize their health care services using geographic, socio-economic and epidemiological data. [More]
Maternal antiretroviral treatment eliminates HIV transmission to infants during breastfeeding

Maternal antiretroviral treatment eliminates HIV transmission to infants during breastfeeding

For HIV-infected mothers whose immune system is in good health, taking a three-drug antiretroviral regimen during breastfeeding essentially eliminates HIV transmission by breast milk to their infants, according to results from a large clinical trial conducted in sub-Saharan Africa and India. [More]
Tecnis Symfony Extended Range of Vision IOL approved for cataract patients

Tecnis Symfony Extended Range of Vision IOL approved for cataract patients

The U.S. Food and Drug Administration today approved the first intraocular lens (IOL) that provides cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision (visual acuity) at near, intermediate and far distances. [More]
Scientists discover new, unexpected features of collagen

Scientists discover new, unexpected features of collagen

Scientists at the National Institutes of Health are reporting new, unexpected details about the fundamental structure of collagen, the most abundant protein in the human body. [More]
FDA approves new ExAblate Neuro to treat patients with essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. [More]
USC, CHLA receive prestigious Clinical and Translational Science Award from NIH

USC, CHLA receive prestigious Clinical and Translational Science Award from NIH

On June 30, 2016, a team of researchers led by Thomas Buchanan, MD, Michele Kipke PhD and Jonathan Samet, MD, of the Keck School of Medicine of the University of Southern California received a prestigious Clinical and Translational Science Award (CTSA) from the National Institutes of Health. [More]
FDA approves new topical retinoid gel for OTC treatment of acne

FDA approves new topical retinoid gel for OTC treatment of acne

The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in people 12 years of age and older. [More]
Healthy weight programs for lesbian and bisexual women aim to achieve changes in lifestyle habits

Healthy weight programs for lesbian and bisexual women aim to achieve changes in lifestyle habits

Lesbian and bisexual women have higher rates of obesity, smoking and stress when compared to their heterosexual counterparts, according to the U.S. Department of Health and Human Services Office on Women's Health. [More]
FDA approves Roche cobas HPV Test to be used with SurePath Preservative Fluid

FDA approves Roche cobas HPV Test to be used with SurePath Preservative Fluid

The U.S. Food and Drug Administration today approved the Roche cobas HPV Test as the first test for Human Papilloma Virus (HPV) that can be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. [More]
Researchers develop conceptual model to improve acute care delivery and outcomes

Researchers develop conceptual model to improve acute care delivery and outcomes

Researchers at the George Washington University created a conceptual model for episodes of acute, unscheduled care - care that can be delivered in a variety of settings from emergency departments to doctors' offices, from urgent care centers to telemedicine. [More]
Group intervention may be effective in improving overall health of aging lesbian, bisexual women

Group intervention may be effective in improving overall health of aging lesbian, bisexual women

The Bay Area has long been one of the nation's leading advocates for LGBT equality and community support. Recent studies, however, reveal that one population -- aging lesbian and bisexual women -- are overlooked in the realm of health care and the promotion of healthy lifestyle choices tailored to their needs. [More]
New study to investigate how genetic factors contribute to breast cancer disparities

New study to investigate how genetic factors contribute to breast cancer disparities

The largest study ever to investigate how genetic and biological factors contribute to breast cancer risk among black women launched today. [More]
PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

PREVAIL IV trial opens in Liberia for EVD survivors with persistent traces of Ebola virus RNA

The Partnership for Research on Ebola Virus in Liberia, a U.S.-Liberia joint Clinical Research Partnership, today announced the opening of PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material, RNA, in their semen. [More]
Advertisement